$4550
The biomedical sensors market is expected to reach US$ 15,338.57 million by 2027 from US$ 8,688.63 million in 2019. The market is estimated to grow at a CAGR of 7.4% from 2020 to 2027.
The growth of the market is attributed to factors such as increase in geriatric population, rise in demand for home-based medical care, technological advancements in the medical device industry, rise in adoption of IoT-based medical devices, and increase in healthcare expenditure worldwide.
Lucrative Regional Markets for Biomedical Sensors
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Incidence of Lifestyle-Based Diseases
Factors such as antimicrobial resistance, adoption of unhealthy lifestyles, alcohol consumption, and smoking contribute to rising prevalence of lifestyle-based diseases, such as diabetes. As per the International Diabetes Federation, in 2019, ~463 million adults had diabetes, and this number is expected to reach 700 million by 2045. Therefore, the demand for biomedical sensors is increasing for regular health monitoring.
Moreover, cardiovascular diseases (CVD) pose a significant threat to human health and lead to a tremendous burden on developed and developing economies worldwide. According to the World Health Organization, CVD accounted for nearly 17.9 million deaths in 2018. This boosts the need for patient monitoring devices to mitigate the death rate caused due to lifestyle-based diseases.
Additionally, rising number of geriatric population and increasing cases of obesity are the factors promoting the health awareness among population. Various established players in the medical device industry have been investing a significant amount in R&D activities to develop better and advanced solutions to cater to the needs of their customers. With the regulations laid down by the government bodies, it is possible to obtain better and reliable health management solutions, ensuring quality care, patient safety, and disease management. For instance, the Centers for Disease Control and Prevention leads efforts to control communicable and infectious disease outbreaks and promote immunization to the people. The federal government also aids states with funding and guidance for emergency preparedness. Thus, the above factors are expected to drive the biomedical sensors market during the forecast period.
Sensor Type-Based Insights
Based on sensor type, the biomedical sensors market is segmented into temperature, pressure, image sensor, biochemical, inertial sensor, motion sensor, electrocardiogram (ECG), and other sensor types. In 2019, the temperature segment accounted for the largest share in the market owing to easy availability and high demand for these sensors. The growing demand for patient monitoring devices in non-hospital settings is also providing attractive growth opportunities for players in the biomedical sensors market. The integration of monitoring technologies in smartphones and wireless devices is a critical trend in patient care, resulting in high growth for patient monitoring applications. This, in turn, is boosting the demand for temperature sensors during the forecast period.
Biomedical Sensors Market, by Sensor Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Type-Based Insights
Based on type, the biomedical sensors market is segmented into wired and wireless. The wireless segment held larger share of the market in 2019, and the same segment is anticipated to register higher CAGR in the market during the forecast period.
Product-Based Insights
In terms of product, the biomedical sensors market is segmented into invasive sensors and non-invasive sensors. The non-invasive sensors segment held larger share of the market in 2019 and is estimated to register the highest CAGR of 7.5% in the market during the forecast period.
Application-Based Insights
Based on application, the biomedical sensors market is segmented into medical diagnostic, clinical therapy, personal healthcare, and imaging. The medical diagnostic segment held the largest share of the market in 2019; however, the personal healthcare segment is expected to register the highest CAGR of 8.2% in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biomedical Sensors Market: Strategic Insights
Market Size Value in US$ 8,688.63 Million in 2019 Market Size Value by US$ 15,338.57 Million by 2027 Growth rate CAGR of 7.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biomedical Sensors Market: Strategic Insights

Market Size Value in | US$ 8,688.63 Million in 2019 |
Market Size Value by | US$ 15,338.57 Million by 2027 |
Growth rate | CAGR of 7.4% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |

Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

The biomedical sensors market players—such as Cognifit; Mango Health; Bunchball; Ayogo Health Inc; Fitbit, Inc.; Akili Interactive Labs, Inc.; Nike, Inc.; Cohero Health, Inc.; Higi Sh Llc; and Mysugr—have been adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in October 2020, TrialCard Incorporated launched a version 2.0 of Mango Health. This latest version provides third-party health service providers with access to Mango’s robust suite of patient support modules. This latest version of the Mango platform will be part of a fully integrated patient support program for the upcoming launch of a novel oral oncolytic.
Biomedical Sensors Market – by Type
- Wired
- Wireless
Biomedical Sensors Market – by Sensor Type
- Temperature
- Pressure
- Image Sensor
- Biochemical
- Inertial Sensor
- Motion Sensor
- Electrocardiogram (ECG)
- Other Sensor Types
Biomedical Sensors Market – by Product
- Invasive Sensors
- Non-Invasive Sensors
Biomedical Sensors Market – by Application
- Medical Diagnostics
- Clinical Therapy
- Imaging
- Personal Healthcare
Biomedical Sensors Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
- Analog Devices, Inc.
- GE Healthcare
- STMicroelectronics
- Honeywell International
- Medtronic
- NXP Semiconductors N.V.
- Pinnacle Technology Inc.
- Sensirion AG
- TE Connectivity
- Texas Instruments Incorporated

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Type , Product , and Application and Geography

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Indonesia, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Sensors are small, tiny, and often intelligent devices that are used to measure physical variables like temperature, humidity, gas, velocity, flow rate, pressure, light, electric fields, and so on. In medicine and biotechnology, biomedical sensors are used to detect specific biological, chemical, or physical processes, which then transmit or report the monitored data. These sensors can also be components in systems that process clinical samples, such as increasingly common lab-on-a-chip devices. Miniaturized biomedical sensors are used for measuring muscle displacement, blood pressure, core body temperature, blood flow, cerebrospinal fluid pressure, and bone growth velocity. With more and more people adopting home healthcare services, the demand for medical instruments that employ biomedical sensors is growing rapidly.
The growth of the market is attributed to factors such growing geriatric population, increasing demand for home-based medical care, technological advancements in the medical device industry, increasing adoption of IoT-based medical devices and rising expenditure on healthcare across the world.
Global biomedical sensors market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The North American region is the largest shareholder and Asia Pacific is the fastest growing market for biomedical sensors. The biomedical sensors market is estimated to have a larger share in the United States. The growth of the biomedical sensors market in the US is expected due to presence of leading players establishing their primary base, rising incidences of acute and chronic diseases among the population and technological advancements in healthcare sector.
The List of Companies - Biomedical Sensors Market
- Analog Devices, Inc.
- GE Healthcare
- STMicroelectronics
- Honeywell International
- Medtronic
- NXP Semiconductors N.V.
- Pinnacle Technology Inc., Sensirion AG
- TE Connectivity
- Texas Instruments Incorporated
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports

Jul 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography

Jul 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography

Jul 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)

Jul 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)

Jul 2021

Jul 2021
Laboratory Animal Diets Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Diet Type (Standard Diet, Irradiated Diet, and Autoclavable Diet), Animal (Mouse, Cat, Dog, Rabbit, Chicken, and Others), Application (Drug Discovery & Personalized Medicine, Regenerative Medicine, Pathology of Infectious Diseases, Drug Toxicity & Efficacy Testing, and Others), and End User (Pharmaceutical & Biopharmaceutical Companies, Research & Academic Institutes, and Others)

Jul 2021
Enzymatic DNA Synthesis Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others), and Technology (SOLA, CRISPR, PCR, and Others)

Jul 2021
Monoclonal Antibodies Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes)